Pfizer won’t charge developed countries less than U.S. for similar vaccine order

Drugmaker Pfizer Inc said on Tuesday no country in the developed world will get a lower price for its experimental COVID-19 vaccine than the United States if those countries make similar volume commitments.

The U.S. government said last week it will pay nearly $2 billion (1.55 billion pounds) to buy enough of the COVID-19 vaccine being developed by Pfizer Inc and German biotech BioNTech SE to inoculate 50 million people if it proves to be safe and effective. That amounts to a $39 price tag.

https://www.marketscreener.com/PFIZER-LIMITED-6493242/news/Pfizer-will-not-charge-developed-countries-less-than-U-S-for-similar-vaccine-order-31004913/